An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome

Ellen W Freeman, Uriel Halbreich, Gary S Grubb, Andrea J Rapkin, Sven O Skouby, Lynne Smith, Sebastian Mirkin, Ginger D Constantine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    70 Citationer (Scopus)

    Abstract

    This article presents an overview of four studies that evaluated a continuous oral contraceptive (OC) containing levonorgestrel (90 mcg) and ethinyl estradiol (20 mcg; LNG/EE) for managing premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS).
    OriginalsprogEngelsk
    TidsskriftContraception
    Vol/bind85
    Udgave nummer5
    Sider (fra-til)437-45
    Antal sider9
    ISSN0010-7824
    DOI
    StatusUdgivet - 2012

    Citationsformater